ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 741898 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 741898; 2) Community: the network communities that were significantly associated with the response to NSC 741898; 3) Molecule: the relationships between components within communities and NSC 741898; 4) MDR: the compounds that were significantly associated with the NSC 741898.

NSC Compound Enrichment Correlation
NSC 755431 Null 0.0352786308082228 0.22625835
NSC 760016 (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one 0.0352786308082228 0.42979131
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.0352786308082228 0.2073497
NSC 84092 Null 0.0352786308082228 0.19753658
NSC 86368 Null 0.0352786308082228 0.26653648
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0378615809326463 0.29330418
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0378615809326463 0.2898472
NSC 18805 .gamma.-Thujaplicine 0.0378615809326463 0.50949262
NSC 303861 L-Cysteine analog 0.0378615809326463 0.58288354
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0378615809326463 -0.015326227
Total:126  Current:102    [First] [Prev] [Next] [Last]